QurAlis to Present Data That Show its Splice-Switching ASOs Restore UNC13A Function in ALS and Frontotemporal Dementia
SV investment has resulted in the approval of 24 novel therapeutics
SV Health Investors bolsters senior biotech team - appoints Nikola Trbovic as Managing Partner and hires Jamil Beg as Partner
Hightop Health adds industry veteran to Board of Directors - Seasoned CEO and McLean Hospital Board Chair joins Hightop’s executive leadership
Merck to Acquire Caraway Therapeutics, Inc.
EyeBio Announces Expansion of Series A to $130 Million, Advances Development of Restoret for Retinal Diseases
SV Health Investors partners with HIT Executives Dave Dyell and Marc Hirshfield to Lead Recapitalization of Innovative Consulting Group
- 8 June 2020SV NewsSV listed 6th in "The Top 50 Most Active Venture Capital Firms in Boston"
- 4 June 2020Portfolio NewsCollaboration aims to develop predictive algorithm for symptoms of COVID-19 by monitoring first responders
- 3 June 2020Portfolio NewsErvaxx rebrands as Enara Bio to reflect a broader emphasis on the discovery and development of novel TCR‐based cancer immunotherapies
- 2 June 2020Portfolio NewsAstronauTx Announces an Alliance With Concept Life Sciences to Accelerate the Identification of Novel Therapies For Alzheimer's Disease
- 29 May 2020Portfolio NewsDeciphera Pharmaceuticals Announces Presentations of Positive Patient Reported Outcomes Results from INVICTUS Phase 3 Study of QINLOCKTM (ripretinib) in Patients with Fourth-Line Advanced GIST at the ASCO 2020 Virtual Scientific Program
- 27 May 2020Portfolio NewsCOVID-19's 'unprecedented stress' on social services drives demand for innovative SDOH programs
- 26 May 2020Portfolio NewsBardy Diagnostics® Announces CE Mark Certification for 14-Day Carnation® Ambulatory Monitor (CAM™) Patch in Europe and Expansion of Home Enrollment Program Amidst COVID-19 Crisis
- 21 May 2020Portfolio NewsSutro Biopharma Expands Senior Management with the Additions of Vice President of Clinical Development and Vice President of Finance and Controller
- 15 May 2020Portfolio NewsFDA Grants Full Approval of Deciphera Pharmaceuticals’ QINLOCK™ (ripretinib) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
- 13 May 2020Portfolio NewsAVROBIO Reports Updated Clinical Data from Investigational Gene Therapy Programs for Fabry Disease and Cystinosis
- 13 May 2020Portfolio NewsQurAlis raises $42 Million Series A Financing to Develop New Therapies for Amyotrophic Lateral Sclerosis (ALS)
- 12 May 2020Portfolio NewsCatabasis Pharmaceuticals Reports First Quarter 2020 Financial Results and Reviews Business Progress